BRIEF published on 11/20/2025 at 07:35, 14 days 23 hours ago Ohio State University Acquires AIXTRON MOCVD System for Advancing Semiconductor Research Semiconductor Innovation AIXTRON MOCVD System Ohio State University Gallium Oxide Nanotech West Lab
PRESS RELEASE published on 11/20/2025 at 07:30, 14 days 23 hours ago Ohio State University selects AIXTRON CCS MOCVD System for Next Generation Gallium Oxide Device Development Ohio State University partners with AIXTRON for GaO device development using advanced MOCVD system. AIXTRON's tool enables high-quality epitaxy of GaO and AlGaO materials AIXTRON MOCVD System Ohio State University GaO Device Development
BRIEF published on 10/30/2025 at 07:35, 1 month 5 days ago AIXTRON Reports Robust FCF Amid Market Challenges in Q3/2025 Semiconductor Industry Free Cash Flow Revenue Guidance Market Demand AIXTRON Financials
PRESS RELEASE published on 10/30/2025 at 07:30, 1 month 5 days ago AIXTRON Q3/2025 with strong FCF, volume shifts and FX headwinds AIXTRON SE reports Q3/2025 financial results with strong FCF, volume shifts, and FX headwinds. Revenues at EUR 119.6 million, FY 2025 guidance adjusted. Order intake at EUR 124.0 million Financial Results FCF AIXTRON SE Q3/2025 FX Headwinds
BRIEF published on 10/17/2025 at 14:45, 1 month 18 days ago AIXTRON Revises 2025 Outlook Amid Market Challenges Revenue Forecast Market Challenges Growth Prospects Q3 2025 Results FX Effects
BRIEF published on 10/17/2025 at 14:43, 1 month 18 days ago AIXTRON SE Revises 2025 Forecast Amid Market Challenges Market Environment AIXTRON SE 2025 Guidance Q3/2025 Results FX Effects
PRESS RELEASE published on 10/17/2025 at 14:40, 1 month 18 days ago AIXTRON reports preliminary Q3/2025 results and adjusts FY 2025 guidance AIXTRON adjusts FY 2025 guidance due to soft market and FX-effects. Preliminary Q3/2025 results show reduced order intake, revenues, gross profit, and EBIT compared to Q3/2024 Market Environment AIXTRON FY 2025 Guidance Q3/2025 Results FX-effects
PRESS RELEASE published on 10/17/2025 at 14:38, 1 month 18 days ago EQS-Adhoc: AIXTRON SE reports preliminary Q3/2025 figures and adjusts FY 2025 guidance AIXTRON SE adjusts FY 2025 guidance due to soft market environment and FX-effects. Q3/2025 figures show order intake at approx. EUR 124 million and revenues at approx. EUR 120 million Market Environment AIXTRON SE FY 2025 Guidance Q3/2025 Figures FX-effects
BRIEF published on 10/07/2025 at 07:35, 1 month 28 days ago AIXTRON Joins 300 mm GaN Power Electronics Program with Hyperion Tool GaN Power Electronics 300 Mm Epitaxial Wafers Hyperion GaN MOCVD Imec Partnership Advanced Semiconductor
PRESS RELEASE published on 10/07/2025 at 07:30, 1 month 28 days ago AIXTRON joins major 300 mm GaN Power Electronic Program with its Hyperion 300 mm GaN tool AIXTRON joins 300 mm GaN Power Electronics Program with Hyperion GaN tool in partnership with imec for advanced power electronics development Technology Partnership AIXTRON Imec GaN Power Electronics Hyperion
Published on 12/05/2025 at 02:35, 4 hours 34 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 9 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 4 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 9 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 39 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 18 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 44 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 54 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 58 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 13 hours 9 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 24 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 25 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
